[go: up one dir, main page]

CA2042605A1 - Proteines inhibitrices de la cytolyse, sequences d'adn codant pour ces proteines, et plasmides, organismes hotes et procedes permettant d'obtenir ces proteines - Google Patents

Proteines inhibitrices de la cytolyse, sequences d'adn codant pour ces proteines, et plasmides, organismes hotes et procedes permettant d'obtenir ces proteines

Info

Publication number
CA2042605A1
CA2042605A1 CA002042605A CA2042605A CA2042605A1 CA 2042605 A1 CA2042605 A1 CA 2042605A1 CA 002042605 A CA002042605 A CA 002042605A CA 2042605 A CA2042605 A CA 2042605A CA 2042605 A1 CA2042605 A1 CA 2042605A1
Authority
CA
Canada
Prior art keywords
cli
protein
cytolysis
inhibitor
cytolysis inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002042605A
Other languages
English (en)
Inventor
Jurg Tschopp
Dieter Jenne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of CA2042605A1 publication Critical patent/CA2042605A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
CA002042605A 1989-10-06 1990-10-08 Proteines inhibitrices de la cytolyse, sequences d'adn codant pour ces proteines, et plasmides, organismes hotes et procedes permettant d'obtenir ces proteines Abandoned CA2042605A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3933850.9 1989-10-06
DE3933850A DE3933850A1 (de) 1989-10-06 1989-10-06 Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins

Publications (1)

Publication Number Publication Date
CA2042605A1 true CA2042605A1 (fr) 1991-04-07

Family

ID=6391217

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002042605A Abandoned CA2042605A1 (fr) 1989-10-06 1990-10-08 Proteines inhibitrices de la cytolyse, sequences d'adn codant pour ces proteines, et plasmides, organismes hotes et procedes permettant d'obtenir ces proteines

Country Status (6)

Country Link
EP (1) EP0452433A1 (fr)
JP (1) JPH04502626A (fr)
AU (1) AU6517790A (fr)
CA (1) CA2042605A1 (fr)
DE (1) DE3933850A1 (fr)
WO (1) WO1991005043A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4223277C2 (de) * 1992-07-15 2001-07-19 Linde Ag Verfahren und Vorrichtung zur Partikelentfernung aus Abgasen von Brennkraftmaschinen
AU4075897A (en) * 1996-08-16 1998-03-06 Roger Lallone A leptin binding protein and its use in methods for diagnosing and treating abnormalities of the endogenous leptin pathway
AU1334101A (en) * 1999-11-02 2001-05-14 Human Genome Sciences, Inc. 19 human secreted proteins
US7199102B2 (en) 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US6930085B2 (en) * 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis
EP1708730A2 (fr) * 2004-01-20 2006-10-11 DeveloGen Aktiengesellschaft Utilisation d'un produit proteique dg47 pour la prevention et le traitement de troubles metaboliques
AU2005314043A1 (en) 2004-12-06 2006-06-15 The Regents Of The University Of California Methods for improving the structure and function of arterioles
ES2543341T3 (es) * 2005-09-13 2015-08-18 National Research Council Of Canada Métodos y composiciones para modular la actividad de células tumorales
HRP20191129T1 (hr) 2009-11-24 2019-09-20 Alethia Biotherapeutics Inc. Anti-klusterinska protutijela i ulomci koji vežu antigen i njihova uporaba za smanjivanje volumena tumora
EA201491568A1 (ru) 2012-02-22 2014-11-28 Алетиа Байотерапьютикс Инк. Совместное применение ингибитора кластерина и ингибитора egfr для лечения рака

Also Published As

Publication number Publication date
EP0452433A1 (fr) 1991-10-23
DE3933850A1 (de) 1991-04-18
WO1991005043A1 (fr) 1991-04-18
AU6517790A (en) 1991-04-28
JPH04502626A (ja) 1992-05-14

Similar Documents

Publication Publication Date Title
JP4411330B2 (ja) 腫瘍壊死因子関連リガンド
US5484885A (en) Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37
RU2627173C2 (ru) Липопротеиновые комплексы и их получение и применения
CA1316132C (fr) Adnc et gene de l'angiogenine humaine (facteur d'angiogenese) et methode d'expression
Reilly et al. cDNA cloning and immunolocalization of a Na (+)-H+ exchanger in LLC-PK1 renal epithelial cells
Ban et al. Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor
JP2757987B2 (ja) ヒト抗‐炎症ホスホリパーゼ阻害蛋白
CA2042605A1 (fr) Proteines inhibitrices de la cytolyse, sequences d'adn codant pour ces proteines, et plasmides, organismes hotes et procedes permettant d'obtenir ces proteines
US7273849B2 (en) ProapolipoproteinA-I mutant and pharmaceutical composition comprising the same for prevention and treatment of atherosclerosis and hyperlipidemia
JP2009171980A (ja) 高トリグリセリド血症を誘発することなくコレステロールレベルを低下するための化合物と方法
US5972702A (en) Osteoclast transporter
JP2002526418A (ja) 血管形成を阻害するための組成物と方法
EP1274717B1 (fr) Composes et methodes permettant de reduire les taux de cholesterol sans induire une hypertriglyceridemie
JPH1084977A (ja) ヒトマクロスカベンジャー受容体
EA004062B1 (ru) Модуляторы функций рецепторов семейства рецепторов tnf/ngf и других белков
US20030082740A1 (en) Histidine proline rich glycoprotein (HPRG) as an anti-angiogenic and anti-tumor agent
KR100260272B1 (ko) Tpo활성을 갖는 단백질의 아미노산을 코딩하는 염기 서열을 포함하는 dna
WO1992017192A1 (fr) Fragments therapeutiques du facteur willebrand
WO1991000907A1 (fr) Proteines chimiotactiques monocytes et peptides associes
WO2000008050A9 (fr) Adn codant pour le gene et la proteine recepteur de l'apolipoproteine b dans les monocytes/macrophages humains
JPH11164693A (ja) 慢性腎不全、アテローム性動脈硬化および繊維症の標的 としての新規なｓＭＡＤ３スプライス変異体
BG106554A (bg) Ген prv-1 и неговото приложение
JP3025248B2 (ja) プロテインｃの活性化を促進するペプチドおよびその抗体の製造法
JP2002085059A (ja) 新規なｔｓｐ１ドメイン含有ポリペプチド
JPH10113195A (ja) 凍結乾燥製剤の製造法

Legal Events

Date Code Title Description
FZDE Dead